Share on LinkedInShare on LinkedIn

ARTICLE · 28 JULY 2015

Product liability: Australian Vioxx class action litigation finally resolved

The long-running representative action brought on behalf of consumers of the arthritis drug, Vioxx, has been settled.

AustraliaConsumer Protection

On 26 February 2015, Justice Jessup of the Australian Federal Court approved a settlement which brought to end the long-running representative (class) action brought on behalf of consumers of the arthritis drug, Vioxx. The settlement approval follows an earlier judgment of Justice Jessup in 2013, in which he had refused to approve a proposed settlement.

The case has had significant implications for product liability class actions. In particular, the Vioxx litigation has highlighted the difficulties in prosecuting healthcare product liability cases as class actions given the importance of varying individual causation issues.
This article was originally published by Pharma In Focus and is reproduced with permission.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from